ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling.
ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling.
Jung-Ying Chiang,Sung-Tai Wei,7 Authors,Chia-Hung Hsieh
2024 · DOI: 10.1038/s41416-024-02581-2
British Journal of Cancer · 3 Citations
TLDR
ABCC4, repressing the cGMP-PKG signalling pathway, is a tumour suppressor in glioblastoma progression and recurrence and constitute a viable translational approach.